Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by HonestAbeon Aug 23, 2017 2:41am
284 Views
Post# 26610917

RE:Intersting company

RE:Intersting company
SolarEclipse wrote: Does not look like they should be value at 60 cents plus with dropping sales

Ill keep a watch on this puppy ...30 cents would be a decent value on a numbers basis and not potential growth


I will counter argue that at 60c the value relative to the current reality is an extremely low risk/high reward opportunity.  The reason being is at 60c the market cap is merely $45M and on an EV basis even lower at $40M.  Despite flat revenue Q over Q, it is still very stable at around $3M, and they still churn out gross margins in low 60%'s which is very healthy.

At $40M EV that is just 3.3x (flat) revenue which is a valuation more inline with something that is in a mature industry that has low margins, and not accurately reflecting Ceapro.

The stock market does not take kindly to lack of growth and furthermore dislikes negative guidance (even more) of continued mediocrity for at least the next two quarters (i.e. running dual plants).  Hence, the negative down draft the stock finds itself in.  But is the situation deserving of a sub $50M EV capitalization?  That one I am not so sure but the market likes to push things to the extreme both on the upside and downside in good times and bad times.

We now all realize 2017 is a transition year, so if you buy into the story (now) you are in for at minimum two years timeframe in order to let their pipeline and related commercialization play out properly.  If you have limited patience then don't get involved now because you will only get further frustrated.  Simple as that.

For disclosure, I have made purchases that I still bag hold at $1.04, $1.02, 67c, 61c along with a couple flip trades that got closed out.
Bullboard Posts